When Growth Comes From Trading Up, Not Showing Up - Scorecard - MDSpire

When Growth Comes From Trading Up, Not Showing Up

<i>Eyecare Business</i> and The Vision Council deliver data-driven insights and practical strategies for eyecare practices navigating market shifts, patient behavior, and industry trends in 2026. Here, The Vision Council highlights a shift as overall consumer spending rose despite declines in patient visits and product volume.

  • By

  • Alysse Henkel

  • Alysse Henkel

  • January 1, 2026

  • 4 min

Share

Clinical Scorecard: When Growth Comes From Trading Up, Not Showing Up

At a Glance

CategoryDetail
ConditionMarket dynamics in the optical industry
Key MechanismsShift towards value-driven decision-making among consumers
Target PopulationEyecare providers and consumers in the optical market
Care SettingEyecare practices

Key Highlights

  • US optical market value reached $69.5 billion in 2025, up 4.4% year over year
  • Declines in patient visits and product volume despite increased spending
  • Consumers are willing to trade up for perceived benefits
  • Replacement cycles lengthened for patients without vision benefits
  • Sunglasses category saw both value and unit volume growth

Guideline-Based Recommendations

Diagnosis

  • Assess patient needs and preferences to guide product recommendations

Management

  • Focus on value-driven conversations and curated product options

Monitoring & Follow-up

  • Track patient spending patterns and preferences over time

Risks

  • Potential for decreased patient visits impacting revenue

Patient & Prescribing Data

Patients in the US optical market

Patients are selective about spending, opting for premium options when benefits are clear

Clinical Best Practices

  • Anchor conversations in patient values
  • Present fewer, well-defined options
  • Make upgrades tangible with demonstrations and comparisons

Related Resources & Content

Original Source(s)

When Growth Comes From Trading Up, Not Showing Up

  • by Alysse Henkel, Alysse Henkel

  • January 1, 2026

Related Content

A Strategic Shift in Vision Healthcare

The clinical and financial imperative for surgical vision correction over conventional optical aids

Dry Eye Dx and Tx: <br>Tailoring the Tear Reservoir</br>

No-Fee CE: Myopia Beyond 2025

This course is designed to help readers understand the development of the disease of myopia. The article identifies areas in which clinicians can intervene to slow progression using the latest research evidence from the past year.